| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 3e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.12 | 7e-05 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |